Holen Sie sich die Stockscreener-App
79.67
0.16%
0.13
Handel nachbörslich:
79.67
Schlusskurs vom Vortag:
$79.54
Offen:
$80.13
24-Stunden-Volumen:
602.94K
Relative Volume:
1.21
Marktkapitalisierung:
$5.31B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-224.29M
KGV:
-20.43
EPS:
-3.9
Netto-Cashflow:
$-185.06M
1W Leistung:
+4.80%
1M Leistung:
+1.68%
6M Leistung:
+11.26%
1J Leistung:
-5.81%
1-Tages-Spanne:
$78.79
$80.66
1-Wochen-Bereich:
$75.09
$81.10
52-Wochen-Spanne:
$55.53
$113.51
Nuvalent Inc Stock (NUVL) Company Profile
Firmenname
Nuvalent Inc
Sektor
Branche
Telefon
508-446-2272
Adresse
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE
Vergleichen Sie NUVL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUVL
Nuvalent Inc
|
79.67 | 5.54B | 0 | -224.29M | -185.06M | -3.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvalent Inc Stock (NUVL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2025-03-14 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-24 | Eingeleitet | UBS | Neutral |
| 2024-08-29 | Eingeleitet | Barclays | Overweight |
| 2024-04-17 | Eingeleitet | Jefferies | Buy |
| 2024-04-01 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-02-28 | Fortgesetzt | Guggenheim | Buy |
| 2024-02-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-09-27 | Eingeleitet | Stifel | Buy |
| 2023-08-08 | Eingeleitet | SVB Securities | Market Perform |
| 2023-07-24 | Eingeleitet | Guggenheim | Buy |
| 2023-01-18 | Eingeleitet | Wedbush | Outperform |
| 2022-06-24 | Eingeleitet | BMO Capital Markets | Outperform |
Alle ansehen
Nuvalent Inc Aktie (NUVL) Neueste Nachrichten
How to build a custom watchlist for Nuvalent Inc.2025 Volume Leaders & High Conviction Investment Ideas - Newser
Advanced analytics toolkit walkthrough for Nuvalent Inc.Weekly Investment Summary & Free Real-Time Volume Trigger Notifications - Newser
Nuvalent:Raymond James initiates coverage with Outperform rating, PT $105. - AInvest
Chart based exit strategy for Nuvalent Inc.Earnings Summary Report & Daily Oversold Stock Bounce Ideas - Newser
When is the best time to exit Nuvalent Inc.Quarterly Trade Summary & Fast Gain Swing Alerts - Newser
Using portfolio simulators with Nuvalent Inc. includedWeekly Trend Recap & Capital Efficient Trade Techniques - Newser
Market reaction to Nuvalent Inc.’s recent newsRate Hike & Daily Growth Stock Investment Tips - Newser
Raymond James Initiates Nuvalent at Outperform With $105 Price Target - MarketScreener
Can technical indicators confirm Nuvalent Inc.’s reversalGold Moves & Fast Exit Strategy with Risk Control - Newser
Is Nuvalent Inc. stock a value trap2025 Bull vs Bear & Daily Growth Stock Tips - khodrobank.com
How institutional ownership impacts Nuvalent Inc. stockWeekly Gains Report & Stepwise Entry/Exit Trade Alerts - Newser
Momentum divergence signals in Nuvalent Inc. chartJuly 2025 Institutional & Safe Investment Capital Preservation Plans - Newser
Can momentum traders help lift Nuvalent Inc.Market Performance Report & Verified Momentum Watchlists - Newser
Best data tools to analyze Nuvalent Inc. stockQuarterly Performance Summary & Target Return Focused Stock Picks - Newser
Analyzing Nuvalent Inc. with risk reward ratio chartsMarket Performance Summary & Low Risk Investment Opportunities - Newser
Top chart patterns to watch in Nuvalent Inc.July 2025 EndofMonth & Capital Protection Trading Alerts - Newser
Piper Sandler Initiates Nuvalent (NUVL) Amid Key Cancer Drug Catalysts - MSN
Is Nuvalent Inc. stock overvalued or fairly pricedVolume Spike & Weekly Momentum Picks - khodrobank.com
How to use a screener to detect Nuvalent Inc. breakoutsInsider Selling & Fast Gain Swing Alerts - Newser
Nuvalent’s (NUVL) Near-Term Catalysts and Precision Oncology Potential: A Case for Undervalued Upside - AInvest
What does recent volatility data suggest for Nuvalent Inc.2025 Support & Resistance & Low Risk Entry Point Guides - Newser
Can Nuvalent Inc. continue delivering strong returnsOptions Play & AI Driven Price Predictions - khodrobank.com
Is Nuvalent Inc. stock a buy or sell2025 Price Targets & Smart Investment Allocation Tips - khodrobank.com
Is Nuvalent Inc. stock forming a triangle patternJuly 2025 Drop Watch & Intraday High Probability Setup Alerts - khodrobank.com
Is Nuvalent Inc. showing insider buyingJuly 2025 Patterns & Low Drawdown Trading Strategies - خودرو بانک
Is Nuvalent Inc. stock entering bullish territoryMarket Performance Summary & Risk Managed Trade Strategies - Newser
Can Nuvalent Inc. rally from current levelsTrade Volume Report & Capital Efficiency Focused Strategies - Newser
Nuvalent Inc. stock outlook for YEARJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser
Will Nuvalent Inc. stock recover after recent dropWeekly Market Report & Risk Controlled Swing Alerts - Newser
Measuring Nuvalent Inc.’s beta against major indicesQuarterly Portfolio Report & Stepwise Trade Signal Implementation - Newser
Leading vs lagging indicators on Nuvalent Inc. performancePortfolio Update Summary & Stepwise Entry/Exit Trade Alerts - Newser
Has Nuvalent Inc. formed a bullish divergenceJuly 2025 Snapshot & Daily Risk Controlled Trade Plans - Newser
What machine learning models say about Nuvalent Inc.Dollar Strength & Community Supported Trade Ideas - Newser
Nuvalent Inc. Sees Spike in Bullish Option Flow getLinesFromResByArray error: size == 0 - newsyoung.net
Finanzdaten der Nuvalent Inc-Aktie (NUVL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nuvalent Inc-Aktie (NUVL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Noci Darlene | Chief Development Officer |
Aug 25 '25 |
Option Exercise |
27.85 |
4,000 |
111,400 |
52,034 |
| Noci Darlene | Chief Development Officer |
Aug 25 '25 |
Sale |
74.62 |
4,000 |
298,489 |
48,034 |
| Porter James Richard | President and CEO |
Aug 15 '25 |
Option Exercise |
18.93 |
27,000 |
511,110 |
276,062 |
| Porter James Richard | President and CEO |
Aug 15 '25 |
Sale |
75.42 |
27,000 |
2,036,325 |
249,062 |
| Pelish Henry E. | Chief Scientific Officer |
Aug 07 '25 |
Option Exercise |
27.71 |
5,500 |
152,415 |
66,456 |
| Pelish Henry E. | Chief Scientific Officer |
Aug 07 '25 |
Sale |
74.85 |
5,500 |
411,675 |
60,956 |
| Noci Darlene | Chief Development Officer |
Jul 30 '25 |
Option Exercise |
27.85 |
4,000 |
111,400 |
52,034 |
| Noci Darlene | Chief Development Officer |
Jul 30 '25 |
Sale |
80.36 |
4,000 |
321,440 |
48,034 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):